Yahoo! Finance: Top Stories

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

Jun 13, 2025 - 17:36
 0
AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal
Read More

Tags:

Previous Article

Moderately bullish activity in PayPal with shares up 0.48%

Next Article

U.K.’s Renold Agrees to $254 Million Private-Equity Takeover by MPE Bidco

Related Posts

The Reason Even Retailers That Raise Prices Want to Keep Your Grocery Bills Down

The Reason Even Retailers That Raise Prices Want to Kee...

Jun 1, 2025  0

What Analysts Think of Costco Stock Ahead of Earnings

What Analysts Think of Costco Stock Ahead of Earnings

May 26, 2025  0

Core Scientific, Inc. (CORZ): Among the Most Promising New Technology Stocks According to Analysts

Core Scientific, Inc. (CORZ): Among the Most Promising ...

May 15, 2025  0